If you’ve been diagnosed with a gynecologic cancer, learning about your disease and its treatment can help you make well-informed decisions and regain a sense of control.
In 2019, ASCO recognizes the progress in treating rare cancers as the Advance of the Year. Impressive progress has been made in bringing new treatment advances to cancers that are rare and difficult to treat. This year’s Clinical Cancer Advances report describes emerging treatments for thyroid cancer, uterine cancer, desmoid tumor, neuroendocrine tumor, and tenosynovial giant cell tumor.
Cancer.Net’s Associate Editors discuss the most exciting research presented at the 2017 ASCO Annual Meeting.
A new study in the Journal of Clinical Oncology finds a link between voluntary weight loss and lower risk of endometrial cancer, a type of uterine cancer.